Insiders Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Real-time Estimate Cboe BZX Other stock markets 15:44:18 13/05/2024 BST			5-day change	1st Jan Change
1.755 ^USD	+0.29%		-4.64%	+334.08%

05-09	Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating	MT
04-30	Perspective Therapeutics, Inc. Announces the Selection of Investigational Product VMT-a-NET for the Treatment of Certain Patients with Neuroendocrine Tumors by the U.S. Food and Drug Administration to Participate in the Chemistry	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Perspective Therapeutics, Inc. Appoints Shane Cobb as Executive Vice President of Operations	11/08/23	CI
Perspective Therapeutics, Inc. Announces Termination of Jennifer Streeter as Chief Operating Officer	14/07/23	CI
Perspective Therapeutics, Inc. Announces Changes to the Board of Directors	15/05/23	CI
Perspective Therapeutics, Inc. Appoints Andrew Bright as Executive Vice-President of Brachytherapy	03/04/23	CI
Isoray, Inc. Announces Termination of William Cavanagh III as Chief Research and Development Officer	10/02/23	CI
Isoray, Inc. has Changed its Name to Perspective Therapeutics, Inc	07/02/23	CI
Isoray, Inc. Announces Management Changes	06/02/23	CI
Isoray, Inc. Announces Executive Changes	06/02/23	CI
Isoray, Inc. Announces CEO Changes	28/09/22	CI
Isoray, Inc. to Appoint Board of Directors	28/09/22	CI
Michael Krachon to Resign as Executive Vice President of Sales and Marketing of Isoray, Effective March 12, 2021	05/03/21	CI
Isoray, Inc. Appoints Lisa Lauer as Vice President Business Development	16/02/21	CI
IsoRay, Inc. Announces Executive Changes	26/06/20	CI
IsoRay, Inc. Appoints Jennifer Streeter as Interim Chief Operating Officer	24/07/19	CI
Isoray, Inc. Announces Executive Changes	19/02/19	CI
IsoRay, Inc. Announces the Appointment of Lori Woods as Chief Executive Officer	17/12/18	CI
IsoRay, Inc. Names Jonathan Hunt as Chief Financial Officer	03/12/18	CI
IsoRay Announces the Resignation of Chairman and CEO Thomas LaVoy; Industry Veteran Lori Woods Appointed Interim CEO; Mick McCormick Appointed Chairman of the Board	05/06/18	GL
IsoRay, Inc. Announces Management Changes	05/06/18	CI
Isoray Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer, Effective July 24, 2017	07/07/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Insiders

Filters